Loading company…
Philadelphia-based Scout Bio develops one-time gene therapies for chronic conditions in pets, starting with anaemia in cats.
Established in 2016 by founder Krishna Polu and based in Pennsylvania, US, Scout Bio, Inc. develops one-time gene therapies for chronic health conditions in companion animals. It uses adeno-associated viral (AAV) vector technology to express therapeutic proteins in vivo. Its lead program targets anaemia linked to chronic kidney disease in cats, and other programs address chronic arthritis pain in cats, which are in clinical trials. The company is at the Series B stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in